What You Should Know
- The Partnership: Jona, an AI-powered gut microbiome startup, has partnered with Everlywell, the dominant U.S. at-home lab testing company, to distribute its advanced diagnostics on a national scale.
- The Technology: Unlike basic stool tests that just look for “good” and “bad” bacteria, the Jona test utilizes deep shotgun metagenomic sequencing. This maps every organism (bacteria, fungi, viruses, and parasites) down to the specific strain level.
- The AI Engine: Jona’s proprietary AI compares the user’s strain-level data against a database of more than 220,000 peer-reviewed scientific studies to pinpoint exact disease and symptom associations.
- The “Digital Twin”: The platform doesn’t just deliver raw data; it creates a “digital twin” of the patient’s microbiome to model how specific dietary, lifestyle, and probiotic interventions will actually shift their gut health, delivering a personalized action plan.
- The Scale: The integration onto the Everlywell platform (which tested roughly 1 in 94 U.S. adults in 2025), high-resolution marks clinical-grade microbiome sequencing is officially moving from a niche biohacker luxury into mainstream consumer diagnostics.
